文献速递复苏、休克与脓毒症创伤与烧伤

主动脉复苏性血管内球囊阻断与复苏性开胸术治疗不可压迫性躯干出血的系统评价与Meta分析

Resuscitative endovascular balloon occlusion of the aorta versus resuscitative thoracotomy for noncompressible torso hemorrhage: A systematic review and meta-analysis.
PubMed 文献 · J Trauma Acute Care Surg · 2026-03-26
一句话结论在经验丰富的团队和结构化创伤体系内,REBOA较RT降低成人创伤性失血性休克或心脏骤停患者的院内死亡率(OR 0.17),但并发症增加。

该系统评价与Meta分析纳入14项比较性观察研究共9028例成人创伤患者(REBOA 2477例,RT 6551例),其中6项研究2912例纳入主要合并分析。REBOA与院内死亡率显著降低相关(OR 0.17,95%CI 0.10-0.28;I²=53.2%;中等确定性证据),失血性休克亚组获益(OR 0.18)大于心脏骤停亚组(OR 0.32),早期死亡率效应最明显(OR 0.12)。REBOA改善神经功能结局但增加并发症(OR 7.81)并延长主动脉阻断时间。作者认为当前证据支持在经验丰富团队和结构化创伤体系内将REBOA作为首选主动脉阻断策略,需进一步研究优化选择标准以降低并发症风险。

要点

  • 成人(≥18岁)创伤性失血性休克或心脏骤停患者中,REBOA较RT院内死亡率显著降低(OR 0.17,95%CI 0.10-0.28;I²=53.2%;中等确定性证据)。
  • 失血性休克亚组REBOA获益(OR 0.18,95%CI 0.12-0.28)大于心脏骤停亚组(OR 0.32,95%CI 0.15-0.69)。
  • 早期死亡率效应最显著(OR 0.12,95%CI 0.07-0.23)。
  • REBOA改善神经功能结局,但并发症发生率显著升高(OR 7.81,95%CI 3.88-15.72)且主动脉阻断时间延长。
  • 作者认为在经验丰富团队和结构化创伤体系内,当前证据支持REBOA作为首选主动脉阻断策略。

适用人群与场景

  • 成人(≥18岁)创伤患者,伴失血性休克或创伤性心脏骤停,需行膈上主动脉阻断。

研究设计与关键结果

  • 系统评价与Meta分析,纳入14项比较性观察研究共9028例患者(REBOA 2477例,RT 6551例),其中6项研究(2912例)纳入主要合并分析。
  • 主要终点:REBOA组院内死亡率显著低于RT组(OR 0.17,95%CI 0.10-0.28;I²=53.2%;中等确定性证据)。
  • 亚组分析:失血性休克组OR 0.18(95%CI 0.12-0.28),心脏骤停组OR 0.32(95%CI 0.15-0.69)。
  • 早期死亡率:OR 0.12(95%CI 0.07-0.23)。
  • 次要终点:REBOA改善神经功能结局,但并发症发生率升高(OR 7.81,95%CI 3.88-15.72),主动脉阻断时间延长。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,证据等级Level III(原文标注)。
  • 中等确定性证据(原文标注)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在经验丰富团队和结构化创伤体系内,当前证据支持REBOA作为首选主动脉阻断策略。
  • 作者建议进一步研究优化患者选择标准和方法以降低并发症风险。
  • REBOA并发症发生率较RT升高(OR 7.81),主动脉阻断时间延长。

指南或共识出处

  • J Trauma Acute Care Surg. 2026;101:162-172.

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) has emerged as a minimally invasive alternative to resuscitative thoracotomy (RT) for noncompressible torso hemorrhage. Comparative effectiveness remains uncertain. This is a systematic review and meta-analysis evaluating the effectiveness and safety of REBOA versus RT in adult trauma patients with exsanguinating hemorrhagic shock or traumatic cardiac arrest.

METHODS: A systematic search of MEDLINE, PubMed, Embase, Scopus, and ClinicalTrials.gov was performed through August 2025 for comparative observational studies assessing REBOA versus RT with supraceliac aortic cross-clamping in adults (≥18 y). The primary outcome was in-hospital mortality, with stratified analyses by physiological state (shock vs. cardiac arrest) and early versus late mortality. Secondary outcomes included overall complications, neurological status, and aortic occlusion metrics.

RESULTS: Fourteen studies comprising 9,028 patients (2,477 REBOA; 6,551 RT) were included; six studies (2,912 patients) contributed to the primary pooled analysis. REBOA was associated with significantly lower in-hospital mortality (OR: 0.17, 95% CI: 0.10-0.28; I2 =53.2%; moderate-certainty evidence). The benefit was greater in hemorrhagic shock (OR: 0.18, 95% CI: 0.12-0.28) than in cardiac arrest (OR: 0.32, 95% CI: 0.15-0.69). Early mortality showed the most substantial effect (OR: 0.12, 95% CI: 0.07-0.23). REBOA improved neurological outcomes but increased complication rates (OR: 7.81, 95% CI: 3.88-15.72) and prolonged aortic occlusion duration.

CONCLUSIONS: REBOA demonstrates superior survival compared with RT in carefully selected patients with trauma, particularly those in hemorrhagic shock. Despite increased complications, current evidence supports REBOA as the preferred aortic occlusion strategy when performed by experienced teams within structured trauma systems. Further research should refine selection criteria and methods to mitigate complication risk. ( J Trauma Acute Care Surg. 2026;101: 162-172. Copyright © 2026 Wolters Kluwer Health, Inc. All rights reserved.).

LEVEL OF EVIDENCE: Systematic Review and Meta-Analysis, Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Londoño Barrientos M, Amarillo Gutierrez D, López Zapata CA, et al. Resuscitative endovascular balloon occlusion of the aorta versus resuscitative thoracotomy for noncompressible torso hemorrhage: A systematic review and meta-analysis. J Trauma Acute Care Surg. 2026. PMID: 41885281. doi:10.1097/TA.0000000000004962

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。